Paul A. Zappala »

Akebia Therapeutics shares owned by Paul A. Zappala

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Paul A. Zappala from 13F filings

Historical chart of Paul A. Zappala investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Paul A. Zappala consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Paul A. Zappala

Quarter filed Position value Share count Share price at filing
2019-03-31 $2.0k 256 7.81
2018-12-31 $1.0k 256 3.91
2018-03-31 $6.0k 650 9.23

More positions owned by Paul A. Zappala

Vanguard European ETF (VGK)
Schwab Emerging Markets Equity ETF (SCHE)
IQ Hedge Multi-Strategy Tracker (QAI)
Vanguard Pacific ETF (VPL)
SPDR S&P MidCap 400 ETF (MDY)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
iShares S&P SmallCap 600 Index (IJR)
Schwab International Equity ETF (SCHF)
iShares S&P MidCap 400 Growth (IJK)
Vanguard Information Technology ETF (VGT)
Health Care SPDR (XLV)
iShares S&P 500 Growth Index (IVW)
Microsoft Corporation (MSFT)
iShares MSCI Canada Index (EWC)
Invesco Exchange Traded Fd T s&p500 eql fin (RSPF)

View all positions for Paul A. Zappala

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics